ClinConnect ClinConnect Logo
Search / Trial NCT06965608

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers

Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · May 2, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Health Literacy Cancer Prevention Health Services Research Implementation Science Latin America And The Caribbean Code Against Cancer (Lac Code)

ClinConnect Summary

This clinical trial is exploring ways to spread important cancer prevention information known as the Latin America and the Caribbean Code Against Cancer. The goal is to see how well different strategies work to share this information in primary healthcare centers in Aparecida de Goiânia. By testing these strategies, researchers aim to improve cancer awareness and prevention efforts in the community.

To participate in this study, you must be an adult (at least 18 years old) and registered at one of the healthcare centers involved. Healthcare professionals who work at these centers for at least three months can also join. Unfortunately, if you have been diagnosed with cancer in the past or are currently receiving cancer treatment, you won’t be eligible. While the study is not yet recruiting participants, those who take part can expect to engage in activities that help improve how cancer prevention information is shared with the public. This trial is an important step toward better health outcomes in the region.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (≥18 years old)
  • Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
  • Healthcare professionals with at least three months of employment at a participating UBS
  • Ability to provide informed consent
  • Exclusion Criteria:
  • - Prior diagnosis of any cancer or currently undergoing cancer treatment

About Hospital Israelita Albert Einstein

Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.

Locations

Aparecida De Goiania, Go, Brazil

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported